PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC).

Affiliation auteurs!!!! Error affiliation !!!!
TitrePACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC).
Type de publicationJournal Article
Year of Publication2016
AuteursGuigay J, Fayette J, Even C, Cupissol D, Rolland F, Peyrade F, Laguerre B, Le Tourneau C, Zanetta S, Le Moal LBozec, Borel C, Do P, Digue L, Delaye J, Auperin A, Bidault F, Costes V, Faivre L
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.6086